The molecular docking results showed that BBR can effectively bind to periodontitis targets ALOX5, AKT1, NOS2, and TNF, indicating that these four targets have high biological activity and can serve as potential biomarkers and key therapeutic targets for BBR treatment of periodontitis. This evidence concerns the gene NOS2 and periodontitis.